🇺🇸 FDA
Patent

US 11839623

Antiviral prodrugs and formulations thereof

granted A61KA61K31/7068A61K31/7076

Quick answer

US patent 11839623 (Antiviral prodrugs and formulations thereof) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/7068, A61K31/7076, A61K47/54, A61K9/146